Trimethylamine N-Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet

J Ren Nutr. 2015 Nov;25(6):459-65. doi: 10.1053/j.jrn.2015.06.004. Epub 2015 Jul 31.

Abstract

Low-protein diet is the recommended nutritional intervention for nondialysis chronic kidney disease (CKD) patients because excess protein intake can damage kidney function and produce uremic toxins. Some of these toxins are generated from amino acids breakdown by gut microbiota as p-cresyl sulfate and indoxyl sulfate that have been clearly associated with cardiovascular mortality in CKD patients. Another uremic toxin, trimethylamine N-oxide (TMAO), a degradation product of choline and L-carnitine (which come mainly from animal protein such as red meat and eggs) is now considered as a proatherogenic metabolite. In the present review, we will highlight the relationship between TMAO, diet and cardiovascular aspects, and the potential concerns about TMAO in nondialysis CKD patients.

Publication types

  • Review

MeSH terms

  • Animals
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / microbiology
  • Carnitine / blood
  • Choline / blood
  • Diet, Protein-Restricted*
  • Disease Models, Animal
  • Eggs
  • Gastrointestinal Microbiome*
  • Humans
  • Methylamines / blood*
  • Methylamines / chemistry
  • Randomized Controlled Trials as Topic
  • Red Meat
  • Renal Insufficiency, Chronic / blood*
  • Renal Insufficiency, Chronic / diet therapy
  • Renal Insufficiency, Chronic / microbiology

Substances

  • Methylamines
  • trimethyloxamine
  • Choline
  • Carnitine